tirzepatide and inflammation is getting attention for weight loss, but its real value may lie in how it supports healthy aging. As a longevity specialist, I'm focused on what it does beneath the surface GLP-1 Medications and Inflammation: Could

The do peptides expire article dispels common myths and clarifies what those dates actually mean

What happens next The FDA is taking public comments through June 29, 2026, before making a final decision

During the randomized period of the study, 26.3% of adults in the tirzepatide group had a treatment-emergent adverse event related to the drug compared with 10.4% of the placebo group

El L-glutatin reducido es la variante bioactiva, que sufre una mnima descomposicin en el intestino y se asimila bien en el organismo

Dysbiosis-induced disruption of the intestinal barrier aggravates DKD by activating inflammatory responses and reducing SCFA levels ( Figure 2 and Figure 4 ) [126]

Dehydration is a realistic concern because reduced appetite naturally leads to lower fluid intake